369 related articles for article (PubMed ID: 17308162)
1. The cardiovascular effects of selective estrogen receptor modulators.
Christodoulakos GE; Lambrinoudaki IV; Botsis DC
Ann N Y Acad Sci; 2006 Dec; 1092():374-84. PubMed ID: 17308162
[TBL] [Abstract][Full Text] [Related]
2. [Selective estrogen receptor modulators (SERMs) in the practice].
Nagykálnai T
Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896
[TBL] [Abstract][Full Text] [Related]
3. Raloxifene, tamoxifen and vascular tone.
Leung FP; Tsang SY; Wong CM; Yung LM; Chan YC; Leung HS; Yao X; Huang Y
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):809-13. PubMed ID: 17600563
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
Michael H; Härkönen PL; Kangas L; Väänänen HK; Hentunen TA
Br J Pharmacol; 2007 Jun; 151(3):384-95. PubMed ID: 17420779
[TBL] [Abstract][Full Text] [Related]
5. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
[TBL] [Abstract][Full Text] [Related]
6. Selective estrogen receptor modulators prevent neointima formation after vascular injury.
Savolainen-Peltonen H; Luoto NM; Kangas L; Häyry P
Mol Cell Endocrinol; 2004 Nov; 227(1-2):9-20. PubMed ID: 15501580
[TBL] [Abstract][Full Text] [Related]
7. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
8. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
9. Estrogens and SERMs in coronary heart disease.
Regitz-Zagrosek V; Wintermantel TM; Schubert C
Curr Opin Pharmacol; 2007 Apr; 7(2):130-9. PubMed ID: 17317318
[TBL] [Abstract][Full Text] [Related]
10. [Selective estrogen-receptor modulators (SERM's) in postmenopausal women].
Hart W; Netelenbos JC
Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1771-6. PubMed ID: 10494328
[TBL] [Abstract][Full Text] [Related]
11. SERMs and cardiovascular disease in women. How do these agents affect risk?
Bush TL; Blumenthal R; Lobo R; Clarkson TB
Postgrad Med; 2001 Mar; Spec No():17-24. PubMed ID: 11296735
[TBL] [Abstract][Full Text] [Related]
12. [An alternative to postmenopausal Hormone Replacement Therapy? Selective Estrogens Receptors Modulators (SERMs)].
Tinelli A; Perrone A; Tinelli FG
Minerva Ginecol; 2001 Apr; 53(2):127-35. PubMed ID: 11319506
[TBL] [Abstract][Full Text] [Related]
13. Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen.
Pole JC; Gold LI; Orton T; Huby R; Carmichael PL
Toxicology; 2005 Jan; 206(1):91-109. PubMed ID: 15590111
[TBL] [Abstract][Full Text] [Related]
14. Selective estrogen receptor modulators.
Haskell SG
South Med J; 2003 May; 96(5):469-76. PubMed ID: 12911186
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
Suuronen T; Nuutinen T; Huuskonen J; Ojala J; Thornell A; Salminen A
Inflamm Res; 2005 May; 54(5):194-203. PubMed ID: 15953991
[TBL] [Abstract][Full Text] [Related]
16. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
17. [Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system].
Fukai S
Clin Calcium; 2008 May; 18(5):677-84. PubMed ID: 18445888
[TBL] [Abstract][Full Text] [Related]
18. [Estrogen receptor and selective estrogen receptor modulators (SERMs)].
Shioi A; Nishizawa Y
Nihon Rinsho; 1999 May; 57(5):1199-207. PubMed ID: 10361456
[TBL] [Abstract][Full Text] [Related]
19. Selective estrogen receptor modulators: an update on recent clinical findings.
Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
